455 related articles for article (PubMed ID: 33020597)
1. The piRNA CHAPIR regulates cardiac hypertrophy by controlling METTL3-dependent N
Gao XQ; Zhang YH; Liu F; Ponnusamy M; Zhao XM; Zhou LY; Zhai M; Liu CY; Li XM; Wang M; Shan C; Shan PP; Wang Y; Dong YH; Qian LL; Yu T; Ju J; Wang T; Wang K; Chen XZ; Wang YH; Zhang J; Li PF; Wang K
Nat Cell Biol; 2020 Nov; 22(11):1319-1331. PubMed ID: 33020597
[TBL] [Abstract][Full Text] [Related]
2. The N
Dorn LE; Lasman L; Chen J; Xu X; Hund TJ; Medvedovic M; Hanna JH; van Berlo JH; Accornero F
Circulation; 2019 Jan; 139(4):533-545. PubMed ID: 30586742
[TBL] [Abstract][Full Text] [Related]
3. A gene therapeutic approach to inhibit calcium and integrin binding protein 1 ameliorates maladaptive remodelling in pressure overload.
Grund A; Szaroszyk M; Döppner JK; Malek Mohammadi M; Kattih B; Korf-Klingebiel M; Gigina A; Scherr M; Kensah G; Jara-Avaca M; Gruh I; Martin U; Wollert KC; Gohla A; Katus HA; Müller OJ; Bauersachs J; Heineke J
Cardiovasc Res; 2019 Jan; 115(1):71-82. PubMed ID: 29931050
[TBL] [Abstract][Full Text] [Related]
4. Lin28a Regulates Pathological Cardiac Hypertrophic Growth Through Pck2-Mediated Enhancement of Anabolic Synthesis.
Ma H; Yu S; Liu X; Zhang Y; Fakadej T; Liu Z; Yin C; Shen W; Locasale JW; Taylor JM; Qian L; Liu J
Circulation; 2019 Apr; 139(14):1725-1740. PubMed ID: 30636447
[TBL] [Abstract][Full Text] [Related]
5. De-ubiquitination of p300 by USP12 Critically Enhances METTL3 Expression and Ang II-induced cardiac hypertrophy.
Lu P; Xu Y; Sheng ZY; Peng XG; Zhang JJ; Wu QH; Wu YQ; Cheng XS; Zhu K
Exp Cell Res; 2021 Sep; 406(1):112761. PubMed ID: 34339675
[TBL] [Abstract][Full Text] [Related]
6. Histone H4R3 symmetric di-methylation by Prmt5 protects against cardiac hypertrophy via regulation of Filip1L/β-catenin.
Cai S; Wang P; Xie T; Li Z; Li J; Lan R; Ding Y; Lu J; Ye J; Wang J; Li Z; Liu P
Pharmacol Res; 2020 Nov; 161():105104. PubMed ID: 32739429
[TBL] [Abstract][Full Text] [Related]
7. Stachydrine hydrochloride suppresses phenylephrine-induced pathological cardiac hypertrophy by inhibiting the calcineurin/nuclear factor of activated T-cell signalling pathway.
Zheng J; Tian J; Wang S; Hu P; Wu Q; Shan X; Zhao P; Zhang C; Guo W; Xu M; Chen H; Lu R
Eur J Pharmacol; 2020 Sep; 883():173386. PubMed ID: 32712088
[TBL] [Abstract][Full Text] [Related]
8. NADPH oxidase-4 promotes eccentric cardiac hypertrophy in response to volume overload.
Schnelle M; Sawyer I; Anilkumar N; Mohamed BA; Richards DA; Toischer K; Zhang M; Catibog N; Sawyer G; Mongue-Din H; Schröder K; Hasenfuss G; Shah AM
Cardiovasc Res; 2021 Jan; 117(1):178-187. PubMed ID: 31821410
[TBL] [Abstract][Full Text] [Related]
9. A Disintegrin and Metalloprotease-22 Attenuates Hypertrophic Remodeling in Mice Through Inhibition of the Protein Kinase B Signaling Pathway.
Ren L; Wu C; Yang K; Chen S; Ye P; Wu J; Zhang A; Huang X; Wang K; Deng P; Ding X; Chen M; Xia J
J Am Heart Assoc; 2018 Jan; 7(2):. PubMed ID: 29358191
[TBL] [Abstract][Full Text] [Related]
10. piRNA-36741 regulates BMP2-mediated osteoblast differentiation via METTL3 controlled m6A modification.
Liu J; Chen M; Ma L; Dang X; Du G
Aging (Albany NY); 2021 Oct; 13(19):23361-23375. PubMed ID: 34645714
[TBL] [Abstract][Full Text] [Related]
11. METTL3 inhibits hepatic insulin sensitivity via N6-methyladenosine modification of Fasn mRNA and promoting fatty acid metabolism.
Xie W; Ma LL; Xu YQ; Wang BH; Li SM
Biochem Biophys Res Commun; 2019 Oct; 518(1):120-126. PubMed ID: 31405565
[TBL] [Abstract][Full Text] [Related]
12. ATF6 Regulates Cardiac Hypertrophy by Transcriptional Induction of the mTORC1 Activator, Rheb.
Blackwood EA; Hofmann C; Santo Domingo M; Bilal AS; Sarakki A; Stauffer W; Arrieta A; Thuerauf DJ; Kolkhorst FW; Müller OJ; Jakobi T; Dieterich C; Katus HA; Doroudgar S; Glembotski CC
Circ Res; 2019 Jan; 124(1):79-93. PubMed ID: 30582446
[TBL] [Abstract][Full Text] [Related]
13. Carboxyl-Terminal Modulator Protein Ameliorates Pathological Cardiac Hypertrophy by Suppressing the Protein Kinase B Signaling Pathway.
Liu X; Yang Q; Zhu LH; Liu J; Deng KQ; Zhu XY; Liu Y; Gong J; Zhang P; Li S; Xia H; She ZG
J Am Heart Assoc; 2018 Jun; 7(13):. PubMed ID: 29945911
[TBL] [Abstract][Full Text] [Related]
14. Lansoprazole alleviates pressure overload-induced cardiac hypertrophy and heart failure in mice by blocking the activation of β-catenin.
Lin H; Li Y; Zhu H; Wang Q; Chen Z; Chen L; Zhu Y; Zheng C; Wang Y; Liao W; Bin J; Kitakaze M; Liao Y
Cardiovasc Res; 2020 Jan; 116(1):101-113. PubMed ID: 30689763
[TBL] [Abstract][Full Text] [Related]
15. METTL3 Modulates Osteoclast Differentiation and Function by Controlling RNA Stability and Nuclear Export.
Li D; Cai L; Meng R; Feng Z; Xu Q
Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32121289
[TBL] [Abstract][Full Text] [Related]
16. FTO-Dependent N
Mathiyalagan P; Adamiak M; Mayourian J; Sassi Y; Liang Y; Agarwal N; Jha D; Zhang S; Kohlbrenner E; Chepurko E; Chen J; Trivieri MG; Singh R; Bouchareb R; Fish K; Ishikawa K; Lebeche D; Hajjar RJ; Sahoo S
Circulation; 2019 Jan; 139(4):518-532. PubMed ID: 29997116
[TBL] [Abstract][Full Text] [Related]
17. Inorganic arsenic induces sex-dependent pathological hypertrophy in the heart.
Kabir R; Sinha P; Mishra S; Ebenebe OV; Taube N; Oeing CU; Keceli G; Chen R; Paolocci N; Rule A; Kohr MJ
Am J Physiol Heart Circ Physiol; 2021 Apr; 320(4):H1321-H1336. PubMed ID: 33481702
[TBL] [Abstract][Full Text] [Related]
18. Sialyltransferase7A promotes angiotensin II-induced cardiomyocyte hypertrophy via HIF-1α-TAK1 signalling pathway.
Yan X; Zhao R; Feng X; Mu J; Li Y; Chen Y; Li C; Yao Q; Cai L; Jin L; Han C; Zhang D
Cardiovasc Res; 2020 Jan; 116(1):114-126. PubMed ID: 30854566
[TBL] [Abstract][Full Text] [Related]
19. Novel Role for Pleckstrin Homology-Like Domain Family A, Member 3 in the Regulation of Pathological Cardiac Hypertrophy.
Liu J; Liu X; Hui X; Cai L; Li X; Yang Y; Shu S; Wang F; Xia H; Li S
J Am Heart Assoc; 2019 Aug; 8(16):e011830. PubMed ID: 31426686
[TBL] [Abstract][Full Text] [Related]
20. OBG-like ATPase 1 inhibition attenuates angiotensin II-induced hypertrophic response in human ventricular myocytes via GSK-3beta/beta-catenin signalling.
Narasimhan G; Henderson J; Luong HT; Rajasekaran NS; Qin G; Zhang J; Krishnamurthy P
Clin Exp Pharmacol Physiol; 2019 Aug; 46(8):743-751. PubMed ID: 31063653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
